Everolimus, a once daily pill that blocks the mTOR pathway, can reduce the size of non-cancerous kidney tumours1 and is licensed today in the UK. Previously embolisation or surgery has been the only option for Tuberous Sclerosis Complex patients with kidney tumours...
More...
More...